Wellington Management Group LLP Akero Therapeutics, Inc. Call Options Transaction History
Wellington Management Group LLP
- $503 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
279Shares Held
85.4MCall Options Held
1MPut Options Held
720K-
Rtw Investments, LP New York, NY7.42MShares$374 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$357 Million0.16% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$282 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$264 Million7.15% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.82MShares$243 Million0.02% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.34B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...